Association between serum levels of GDF-15, suPAR, PIVKA-II, sdLDL and clinical outcomes in hospitalized COVID-19 patients
Internal and Emergency Medicine · 2024-09 · 19 (6) · 1557-1566
DOI: 10.1007/s11739-024-03630-7 ↗Kurz gefasst
Fachartikel in der Zeitschrift Internal and Emergency Medicine, online erschienen am 03.05.2024. Verfasst von Alessio Molfino und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. alessio.molfino@uniroma1.it. Hauptthemen laut MEDLINE: COVID-19, Growth Differentiation Factor 15, Biomarkers. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Sapienza Università di Roma, Università degli Studi di Roma La Sapienza.
Abstract (Originalsprache)
To quantify the circulating levels of novel serum biomarkers including GDF-15, PIVKA-II, sdLDL, suPAR, and of CRP in hospitalized COVID-19 patients compared with healthy subjects, and to evaluate their association(s) with outcomes in COVID-19. We considered patients with confirmed COVID-19, hospitalized in an Internal Medicine ward. The clinical characteristics were collected, including the number and type of comorbidities. Serum levels of GDF-15, PIVKA-II, suPAR, sdLDL, as well as CRP were measured. As outcomes, we considered Intensive Care Unit (ICU) transfer or death, as well as the length of stay (days) and in-hospital complications. Data were statistically analyzed, as appropriate, and a p value < 0.05 was considered significant. Ninety-three patients and 20 healthy controls were enrolled. COVID-19 patients vs. controls showed higher median levels of GDF-15 ( p < 0.0001), PIVKA-II ( p < 0.0001) and sdLDL ( p = 0.0002), whereas no difference was observed for suPAR. In COVID-19 patients, the most frequent comorbidities were arterial hypertension (62.4%) and cardiovascular disease (30.1%). GDF-15 levels positively correlated with age ( r = 0.433, p < 0.0001), and this correlation was confirmed for suPAR ( r = 0.308, p = 0.003) and CRP (Rho = 0.40 p < 0.0001), but not for PIVKA-II and sdLDL. Higher GDF-15 levels were associated with a higher number of comorbidities ( p = 0.021). The median length of stay was 22 (15; 30) days. During hospitalization, 15 patients (16%) were ICU transferred, and 6 (6.45%) died. GDF-15 serum levels correlated with the length of stay (rho = 0.27 p = 0.010), and were associated with ICU transfer or death ( p = 0.003), as well as PIVKA-II ( p = 0.038) and CRP ( p < 0.001). Moreover, higher GDF-15 and PIVKA-II serum levels were associated with infectious complications ( p = 0.008 and p = 0.017, respectively). In this cohort of hospitalized COVID-19 patients, novel inflammatory biomarkers, including GDF-15, suPAR and PIVKA II were associated with some patient’s clinical characteristics, complications, and poor outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy. alessio.molfino@uniroma1.it.
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy. emanuela.anastasi@uniroma1.it.
- Department of Molecular Medicine, Sapienza University of Rome, Rome, Italy. emanuela.anastasi@uniroma1.it.
- Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
- Department of Experimental Medicine, Sapienza University of Rome, Rome, Italy.
- National HIV/AIDS Center, Istituto Superiore Di Sanità, Rome, Italy.
ORCID-Profile: Alessio Molfino
Förderung
- Sapienza Università di Roma
- Università degli Studi di Roma La Sapienza
Zitieren
APA
Molfino, A., Anastasi, E., Assanto, E., Toccini, L., Imbimbo, G., Gigante, A., Viggiani, V., Farina, A., Picconi, O., Angeloni, A., & Muscaritoli, M. (2024). Association between serum levels of GDF-15, suPAR, PIVKA-II, sdLDL and clinical outcomes in hospitalized COVID-19 patients. Internal and Emergency Medicine, 19(6), 1557-1566. https://doi.org/10.1007/s11739-024-03630-7
Vancouver
Molfino A, Anastasi E, Assanto E, Toccini L, Imbimbo G, Gigante A, et al. Association between serum levels of GDF-15, suPAR, PIVKA-II, sdLDL and clinical outcomes in hospitalized COVID-19 patients. Internal and Emergency Medicine. 2024;19(6):1557-1566. doi:10.1007/s11739-024-03630-7
BibTeX
@article{Molfino2024,
author = {Molfino, Alessio and Anastasi, Emanuela and Assanto, Eleonora and Toccini, Ludovica and Imbimbo, Giovanni and Gigante, Antonietta and Viggiani, Valentina and Farina, Antonella and Picconi, Orietta and Angeloni, Antonio and Muscaritoli, Maurizio},
title = {Association between serum levels of GDF-15, suPAR, PIVKA-II, sdLDL and clinical outcomes in hospitalized COVID-19 patients},
journal = {Internal and Emergency Medicine},
year = {2024},
volume = {19},
number = {6},
pages = {1557--1566},
doi = {10.1007/s11739-024-03630-7}
}
EUVIMED